beta-Blockade and recurrent myocardial infarction.
作者信息
Jones R J
出版信息
JAMA. 1982 Apr 16;247(15):2141-2.
PMID:7038178
Abstract
摘要
相似文献
1
beta-Blockade and recurrent myocardial infarction.β受体阻滞剂与复发性心肌梗死
JAMA. 1982 Apr 16;247(15):2141-2.
2
Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.急性心肌梗死患者的普萘洛尔治疗：β受体阻滞剂心肌梗死试验
Circulation. 1983 Jun;67(6 Pt 2):I53-7.
3
Intravenous beta-blockade during acute myocardial infarction.急性心肌梗死期间的静脉β受体阻滞剂治疗
Lancet. 1986 Jul 12;2(8498):79-80.
4
Beta-adrenergic blockade after myocardial infarction.心肌梗死后的β-肾上腺素能阻滞剂治疗
N Engl J Med. 1981 Apr 2;304(14):837-8. doi: 10.1056/NEJM198104023041409.
5
Does sulphinpyrazone prevent recurrence of myocardial infarction?
Lancet. 1982 Mar 27;1(8274):735-6. doi: 10.1016/s0140-6736(82)92639-3.
6
7
Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.心肌梗死后的β受体阻滞剂治疗：挪威高危患者普萘洛尔研究
Circulation. 1983 Jun;67(6 Pt 2):I57-60.
8
Mortality in the beta blocker heart attack trial: circumstances surrounding death.β受体阻滞剂心肌梗死试验中的死亡率：死亡相关情况
J Chronic Dis. 1987;40(1):75-82. doi: 10.1016/0021-9681(87)90098-1.
9
The Beta-blocker Heart Attack Trial.
Z Kardiol. 1985;74 Suppl 6:159-63.
10
Protective effect of propranolol in threatened myocardial infarction.普萘洛尔对急性心肌梗死的保护作用。
Lancet. 1978 Oct 28;2(8096):907-9. doi: 10.1016/s0140-6736(78)91628-8.
引用本文的文献
1
Clinical trials versus clinical practice in the secondary prevention of myocardial infarction.心肌梗死二级预防中的临床试验与临床实践
Eur J Clin Pharmacol. 1994;46(2):95-9. doi: 10.1007/BF00199869.
Zotero 插件